DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 100 filers reported holding DICERNA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $897,000 | +45.9% | 24,038 | 0.0% | 0.03% | +34.8% |
Q1 2021 | $615,000 | +220.3% | 24,038 | +83.5% | 0.02% | +91.7% |
Q1 2019 | $192,000 | -89.7% | 13,100 | -89.3% | 0.01% | -89.0% |
Q3 2018 | $1,869,000 | +206.4% | 122,500 | +146.0% | 0.11% | +202.8% |
Q2 2018 | $610,000 | – | 49,800 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 4,080,237 | $74,954,000 | 12.68% |
Aquilo Capital Management, LLC | 1,237,379 | $22,731,000 | 8.86% |
EcoR1 Capital, LLC | 3,346,301 | $61,472,000 | 6.42% |
RTW INVESTMENTS, LP | 6,963,135 | $127,913,000 | 5.51% |
BRIDGER MANAGEMENT, LLC | 1,679,344 | $30,850,000 | 3.57% |
Parkman Healthcare Partners LLC | 300,805 | $5,526,000 | 2.56% |
ACUTA CAPITAL PARTNERS, LLC | 256,500 | $4,712,000 | 2.28% |
Integral Health Asset Management, LLC | 185,000 | $3,398,000 | 1.50% |
DAFNA Capital Management LLC | 147,714 | $2,714,000 | 1.13% |
EAM Global Investors LLC | 88,465 | $1,625,000 | 0.95% |